Table 9. Clinical trials for epilepsy treatment registered in the database of the USA National Institute of Health (www.ClinicalTrials.gov).
| Identifier | Study Design - Intervention Model | Study Design - Allocation | Study Design - Masking | Intervention | Phase | Status |
|---|---|---|---|---|---|---|
| NCT00212745 | Single Group Assignment | Non-randomized | None | Behavioral: Andrews/Reiter behavioral treatment | I, II | Completed |
| NCT02983695 | Single Group Assignment | N/A | None | Drug: TIL-TC150 | I | Active, not recruiting |
| NCT02987114 | Single Group Assignment | N/A | None | Drug: PLT101 | II | Completed |
| NCT03370120 | Single Group Assignment | N/A | None | Drug: padsevonil | II, III | Enrolling by invitation |
| NCT03428360 | Single Group Assignment | N/A | None | Drug: DBSF (diazepam buccal soluble film) | III | Active, not recruiting |
| NCT01728077 | Single Group Assignment | N/A | None | Drug: brivaracetam | III | Completed |
| NCT02726919 | Single Group Assignment | N/A | None | Drug: clobazam | IV | Unknown |
| NCT01235403 | Single Group Assignment | N/A | None | Drug: lacosamide | IV | Completed |
| NCT01689649 | Single Group Assignment | N/A | None | Drug: topiramate | IV | Completed |
| NCT01311440 | Parallel Assignment | Randomized | None | Other: modified Atkins diet treatment | N/A | Completed |
| NCT02076698 | Parallel Assignment | Randomized | None | Procedure: anterior nucleus (of thalamus) deep brain stimulation (AN-DBS) | III | Active, not recruiting |
| NCT01405508 | Parallel Assignment | Randomized | None | Drug: brivaracetam | III | Completed |
| NCT01645072 | Parallel Assignment | Randomized | None | Other: low glycemic index diet | III | Unknown |
| NCT01028456 | Parallel Assignment | Randomized | Double | Other: light therapy | N/A | Unknown |
| NCT00355082 | Parallel Assignment | Randomized | Double | Drug: lamotrigine | III | Completed |
| NCT01745952 | Crossover Assignment | Randomized | Triple | Device: Repetitive Transcranial Magnetic Stimulation (rTMS) coil | N/A | Completed |
| NCT03283371 | Parallel Assignment | Randomized | Triple | Drug: natalizumab | II | Active, not recruiting |
| NCT01228747 | Parallel Assignment | Randomized | Triple | Drug: levetiracetam | III | Completed |
| NCT01389596 | Parallel Assignment | Randomized | Triple | Drug: pregabalin add-on therapy | III | Completed |
| NCT01999777 | Parallel Assignment | Randomized | Triple | Drug: USL261 | III | Completed |
| NCT03852303 | Parallel Assignment | Randomized | Triple | Drug: ivermectin | IV | Completed |
| NCT03166215 | Parallel Assignment | Randomized | Quadruple | Drug: TAK-935 | I, II | Completed |
| NCT03796962 | Parallel Assignment | Randomized | Quadruple | Drug: XEN1101 | II | Recruiting |